|
2024
|
Invention
|
Uses of pan bet inhibitors. The present disclosure relates to methods for the treatment, ameliora... |
|
2022
|
Invention
|
Uses of pan bet inhibitors.
The present disclosure relates to methods for the treatment, amelior... |
|
|
P/S
|
Pharmaceuticals; pharmaceutical preparations.. |
|
2021
|
P/S
|
Pharmaceutical preparations for treating inflammatory disorders or diseases and autoimmune disord... |
|
|
Invention
|
Tofacitinib-containing anhydrous elastomer-based gel formulations.
The present disclosure relate... |
|
|
Invention
|
Tofacitinib-containing anhydrous elastomer-based gel formulations. The present disclosure relates... |
|
2020
|
Invention
|
Topical composition comprising tofacitinib and fingolimod.
The present disclosure relates to nov... |
|
|
Invention
|
Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof. The present invention... |
|
|
P/S
|
Anti-inflammatory dermatological pharmaceutical preparations; dermatological pharmaceutical prepa... |
|
|
P/S
|
Dermatological pharmaceutical preparations. |
|
|
P/S
|
Pharmaceutical preparations; dermatological pharmaceutical preparations. |
|
|
P/S
|
Anti-inflammatory pharmaceutical preparations; pharmaceutical preparations for use in treating au... |
|
|
P/S
|
Pharmaceutical preparations for use in the treatment of inflammatory disorders; dermatological ph... |
|
|
Invention
|
Tetracycline management of egfr inhibitor associated dermatoses.
Methods of treatment and dosage... |
|
|
P/S
|
dermatological pharmaceutical preparations |
|
|
Invention
|
Use of nk-1 receptor antagonist serlopitant in pruritus. The invention relates to methods for tre... |
|
2019
|
Invention
|
Use of neurokinin-1 antagonists to treat pruritus.
The disclosure relates to the use of neurokin... |
|
|
Invention
|
Wax foamable vehicle and pharmaceutical compositions thereof. Unique foamable vehicles or carrier... |
|
|
Invention
|
Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foa... |
|
|
Invention
|
Use of nk-1 receptor antagonists in pruritus. The invention relates to methods for treating pruri... |
|
2017
|
Invention
|
Use of neurokinin-1 antagonists to treat a variety of pruritic conditions.
The disclosure relate... |
|
|
Invention
|
Hydroalcoholic foam formulations of naftifine.
The present disclosure relates to topical, hydroa... |
|
2015
|
Invention
|
Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses. A substanti... |
|
|
P/S
|
Toiletries and cosmetics for personal skin care; formulations for personal hygiene; emollients; p... |
|
|
Invention
|
Apparatus and method for releasing a unit dose of content from a container. A apparatus for deliv... |
|
2014
|
Invention
|
Foamable carriers. The invention relates to an alcohol-free cosmetic or therapeutic foam carrier ... |
|
|
Invention
|
Penetrating pharmaceutical foam. The invention relates to an alcohol-free cosmetic or pharmaceuti... |
|
|
Invention
|
Oleaginous pharmaceutical and cosmetic foam. The invention relates to stable oleaginous cosmetic ... |
|
|
Invention
|
Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and ... |
|
|
Invention
|
Foam prepared from nanoemulsions and uses. The present invention provides a foamable composition ... |
|
2013
|
Invention
|
Compositions with modulating agents. The present invention relates to a waterless composition and... |
|
|
Invention
|
Foamable vehicle and pharmaceutical compositions thereof. A hygroscopic pharmaceutical compositio... |
|
|
Invention
|
Foamable carriers. The invention relates to an alcohol-free cosmetic or therapeutic foam carrier... |
|
2012
|
Invention
|
Foamable compositions. The present invention is related to a foamable composition of matter compr... |
|
2009
|
Invention
|
Sensation modifying topical composition foam. This invention relates to foamable compositions tha... |
|
2004
|
P/S
|
Toiletries and cosmetics for personal skin care; formulations for personal hygiene, namely, emoll... |
